Evidence map›Paper›PMID 39274636›Full record

ArticleMaterials (Basel, Switzerland)2024

Nanocrystalline Cellulose to Reduce Superplasticizer Demand in 3D Printing of Cementitious Materials.

Rocío Jarabo, Elena Fuente, José Luis García Calvo, Pedro Carballosa, Carlos Negro

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rocío JaraboInstituto de Ciencias de la Construcción "Eduardo Torrjoja" (CSIC), C/Serrano Galvache 4, 28033 Madrid, Spain.
Elena FuenteChemical Engineering and Materials Department, University Complutense of Madrid, Avda. Complutense s/n, 28040 Madrid, Spain.ORCID 0000-0003-0421-4607
José Luis García CalvoInstituto de Ciencias de la Construcción "Eduardo Torrjoja" (CSIC), C/Serrano Galvache 4, 28033 Madrid, Spain.ORCID 0000-0002-0042-9822
Pedro CarballosaInstituto de Ciencias de la Construcción "Eduardo Torrjoja" (CSIC), C/Serrano Galvache 4, 28033 Madrid, Spain.ORCID 0000-0002-3717-7614
Carlos NegroChemical Engineering and Materials Department, University Complutense of Madrid, Avda. Complutense s/n, 28040 Madrid, Spain.

Funding

Centre for Industrial Technological Development SNEO-20181016Economy and Competitiveness Ministry of Spain CTQ2017-85654-C2-1-REconomy and Competitiveness Ministry of Spain CTQ2017-85654-C2-2-RNEOTEC program 419-2018
6 · The paper itself

Abstract

One challenge for 3D printing is that the mortar must flow easily through the printer nozzle, and after printing, it must develop compressive strength fast and high enough to support the layers on it. This requires an exact and difficult control of the superplasticizer (SP) dosing. Nanocrystalline cellulose (CNC) has gained significant interest as a rheological modifier of mortar by interacting with the various cement components. This research studied the potential of nanocrystalline cellulose (CNC) as a mortar aid for 3D printing and its interactions with SPs. Interactions of a CNC and SP with cement suspensions were investigated by means of monitoring the effect on cement dispersion (by monitoring the particle chord length distributions in real time) and their impact on mortar mechanical properties. Although cement dispersion was increased by both CNC and SP, only CNC prevented cement agglomeration when shearing was reduced. Furthermore, combining SP and CNC led to faster development of compressive strength and increased compressive strength up to 30% compared to mortar that had undergone a one-day curing process.

Indexed as

3D printingcement mortarcompressive strengthmechanical resistancenanocrystalline cellulose

Identifiers

PMID39274636
PMCPMC11396721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.